EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Roadmap for HCC Surveillance and Management in the Asia Pacific

Masatoshi Kudo iD, Bui Thi Oanh iD, Chien-Jen Chen iD, Do Thi Ngat, Jacob George iD, Do Young Kim iD, Luckxawan Pimsawadi, Pisit Tangkijvanich, Raoh-Fang Pwu, Rosmawati Mohamed, Sakarn Bunnag, Sheng-Nan Lu iD und 6 weitere

Cancers · 10.06.2025 · 17 (12) · 1928

DOI: 10.3390/cancers17121928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 10.06.2025. Verfasst von Masatoshi Kudo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, with the Asia-Pacific (APAC) region bearing a disproportionate burden. This paper examines HCC challenges within seven APAC health systems, identifies key barriers at each stage of the patient journey, and proposes tailored, actionable solutions. To effectively address HCC challenges, a stepwise approach should prioritise high-impact solutions, focusing on prevention, early diagnosis, and expanding surveillance to maximise health outcomes and economic benefits, while tailoring strategies to each health system’s unique resources and constraints.

Methods

A mixed-methods approach was used, including expert consultations from the 2024 HCC APAC Policy Forum, a literature review, and a review of Japan’s HCC management model. Data were collected through workshops and stakeholder feedback from healthcare professionals, policymakers, researchers and patient advocates across Australia, India, Malaysia, South Korea, Taiwan, Thailand, and Vietnam.

Results

Key findings include significant disparities in HCC awareness, prevention, early detection, diagnosis, and access to treatment. Common challenges across APAC include limited public awareness, suboptimal surveillance infrastructure, and financial barriers to care. The integration of novel biomarkers and advanced surveillance modalities were identified as crucial priorities for improving early detection. Japan’s multi-faceted approach to HCC management serves as a successful model for the region.

Conclusions

A customised and targeted approach is essential for reducing the HCC burden across APAC. The proposed recommendations, tailored to each health system’s needs, can significantly improve patient outcomes and reduce healthcare costs. Effective collaboration among stakeholders is necessary to drive these changes.

Schlagwörter

Stichwörter der Autor:innen

Asia-PacificHCC awarenessHCC early detectionHCC preventionHCC surveillanceHCC surveillance and managementHCC treatment accesshealthcare systemshepatocellular carcinomapolicyregional healthcare challenges

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan.
  • Department of Epidemiology, National Cancer Hospital, Hanoi 100000, Vietnam.
  • Genomics Research Center, Academia Sinica, Nangang District, Taipei City 115, Taiwan.
  • Medical Profession & Officer Health Protection Division, Department of Medical Service Administration, Vietnam Ministry of Health, Hanoi 11110, Vietnam.
  • Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney, Sydney, NSW 2145, Australia.
  • College of Medicine, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.

ORCID-Profile: Masatoshi Kudo, Bui Thi Oanh, Chien-Jen Chen, Jacob George, Do Young Kim, Sheng-Nan Lu, Teerha Piratvisuth

Zitieren

APA

Kudo, M., Oanh, B. T., Chen, C. J., Ngat, D. T., George, J., Kim, D. Y., Pimsawadi, L., Tangkijvanich, P., Pwu, R. F., Mohamed, R., Bunnag, S., Lu, S. N., Kudtiyakarn, S., Kanto, T., Piratvisuth, T., Wu, C. C., Sarno, R., & APAC Liver Disease Alliance (2025). Roadmap for HCC Surveillance and Management in the Asia Pacific. Cancers, 17(12), 1928. https://doi.org/10.3390/cancers17121928

Vancouver

Kudo M, Oanh BT, Chen CJ, Ngat DT, George J, Kim DY, et al. Roadmap for HCC Surveillance and Management in the Asia Pacific. Cancers. 2025;17(12):1928. doi:10.3390/cancers17121928

BibTeX
@article{Kudo2025,
  author = {Kudo, Masatoshi and Oanh, Bui Thi and Chen, Chien-Jen and Ngat, Do Thi and George, Jacob and Kim, Do Young and Pimsawadi, Luckxawan and Tangkijvanich, Pisit and Pwu, Raoh-Fang and Mohamed, Rosmawati and Bunnag, Sakarn and Lu, Sheng-Nan and Kudtiyakarn, Sirintip and Kanto, Tatsuya and Piratvisuth, Teerha and Wu, Chao-Chun and Sarno, Roberta and APAC Liver Disease Alliance, APAC Liver Disease Alliance},
  title = {Roadmap for HCC Surveillance and Management in the Asia Pacific},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {12},
  pages = {1928},
  doi = {10.3390/cancers17121928}
}
Kostenlos starten →